FDA PMA
FDA Class 3
30-Day Notice Accepted
🇺🇸 United States
Pump, Infusion, Implanted, Programmable
PMA: P140032
·
Supplement: S054
·
Decision May 14, 2020
Classifications
1
FEI Numbers
18
Registration Numbers
18
Basic Information
- Device Name
- Pump, Infusion, Implanted, Programmable
- Trade Name
- Implantable System for Remodulin
- PMA Number
- P140032
- Supplement Number
- S054
- Device Class
- FDA Class 3
- Product Code
- LKK
- Generic Name
- Pump, infusion, implanted, programmable
- Medical Specialty
- Unknown
- Advisory Committee
- General Hospital
- Decision
- 30-Day Notice Accepted
- Decision Code
- OK30
- Decision Date
- May 14, 2020
- Date Received
- April 16, 2020
- Supplement Type
- 30-Day Notice
- Supplement Reason
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
- Expedited Review
- N
Advisory Committee Statement
SynchroMed II Implantable Infusion Pump and Implantable System for Remodulin the creation of new supplier tooling, automation of an existing supplier test system, and modification of supporting component and device drawings for component assemblies.
Classifications
This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.
| Product Code | Device Name | Device Class | Medical Specialty |
|---|---|---|---|
| LKK | Pump, Infusion, Implanted, Programmable | FDA class 3 | Unknown |